News and Analysis
Innovation, Technology, and IP News
Promises Made, Promises Not Kept: Even an Implied License Requires Compliance With Its Terms
BITMANAGEMENT SOFTWARE GMBH v. UNITED STATES Before NEWMAN, DYK, and O’MALLEY, Circuit Judges. Appeal from the United States Court of Federal Claims. Summary: The U.S...
Collateral Estoppel in AIA Trial Proceedings
Inconsistency Across Related Cases is Precluded When challenging related patents at the Patent Trial & Appeal Board (PTAB), it is not uncommon to present similar grounds of...
Patexia Insight 100: Patents Down in 2020 and the downtrend May Continue
Last year we wrote about the impact of the pandemic on the US patent activity and the patent prosecution practice (Patexia Insight 79). We estimated a drop of 2 to 4 percent in the...
Feed tagged as "anda":
2020 Pandemic brought so many changes to our life styles. Some speculate that the huge rise in patent litigation was due to COVID-19. While pandemic might have had... Read More »
VALEANT PHARMACEUTICALS v. MYLAN PHARMACEUTICALS
Before Newman, O’Malley, and Taranto. Appeal from the District Court of New Jersey
Summary: Venue ... Read More »
Update: Thanks to one of our readers who discovered an error in our ITC numbers for Q3. We have already updated the article with the correct data.
The third... Read More »
This morning we released our first ANDA Litigation Intelligence Report. For the first time, we ranked all attorneys and law firms by their activity and performance... Read More »
IBSA INSTITUT BIOCHIMIQUE, S.A. V. TEVA PHARMACEUTICALS USA, INC.
Before Prost, Reyna, and Hughes. Appeal from the District Court of Delaware
Summary: A ... Read More »
The first half of 2020 is over and so far this year has been very challenging for all sectors of the economy. The legal sector has not been very different. Some law... Read More »
Running a profitable patent prosecution practice has become more challenging in recent years. The recession triggered by the current pandemic is going to make this... Read More »
VALEANT PHARMACEUTICALS INTL. v. MYLAN PHARMACEUTICALS INC.
Before Lourie, Reyna, and Hughes. Appeal from the United States District Court for the District... Read More »
Federal Circuit Summary
Before Lourie, Dyk, and Taranto. Appeal from the District Court for the District of Delaware.
Summary: A passing reference ... Read More »
Federal Circuit Summary
Before Prost, Lourie and Hughes. Appeal from the United States District Court for the District of Delaware.
Summary: When... Read More »
Written by Jane Xia and Jing Liu, Ph.D.
MILLENNIUM PHARMACEUTICALS, INC. v. SANDOZ INC
(Fed. Cir. July 17, 2017) (NEWMAN, Mayer, O’Malley)
This case ... Read More »
Written by Peter Heuser, Schwabe Williamson & Wyatt
In Shire, the panel rejects defendant’s attempt to read “consisting of” as though... Read More »
In Intendis v Glenmark, the Federal Circuit affirmed a finding of infringement under the doctrine of equivalents based on statements made by Glenmark to the... Read More »
Comments
Curtis LeeSo in essence, the doctrine of estoppel is being applied to statements or positions taken outside the courtroom?
Oct 12, 2016
Jeff McIntyreNot necessarily estoppel. More like reliable evidence which can help prove the fact and which is difficult to rebut
Oct 12, 2016
